Projected Income Statement: Yara International ASA

Forecast Balance Sheet: Yara International ASA

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 24,846 34,729 33,094 38,967 41,985 31,422 27,955 25,363
Change - 39.78% -4.71% 17.75% 7.75% -25.16% -11.03% -9.27%
Announcement Date 2/9/21 2/8/22 2/8/23 2/9/24 2/7/25 - - -
1NOK in Million
Estimates

Cash Flow Forecast: Yara International ASA

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
CAPEX 1 6,267 7,149 9,559 12,028 11,684 12,136 12,332 12,538
Change - 14.08% 33.7% 25.83% -2.86% 3.87% 1.61% 1.68%
Free Cash Flow (FCF) 1 19,462 5,276 15,123 12,133 2,792 8,750 9,257 6,985
Change - -72.89% 186.65% -19.77% -76.99% 213.44% 5.79% -24.54%
Announcement Date 2/9/21 2/8/22 2/8/23 2/9/24 2/7/25 - - -
1NOK in Million
Estimates

Forecast Financial Ratios: Yara International ASA

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027

Profitability

        
EBITDA Margin (%) 18.43% 17.4% 20.33% 11.01% 14.72% 15.97% 16.05% 15.9%
EBIT Margin (%) 12.24% 6.47% 15.91% 2.01% 7.21% 8.91% 8.72% 8.57%
EBT Margin (%) 7.25% 4.45% 15.13% 1.23% 1.29% 7.73% 7.75% 7.59%
Net margin (%) 5.89% 2.72% 11.55% 0.31% 0.1% 5.92% 5.88% 5.72%
FCF margin (%) 19.49% 3.62% 6.06% 7.35% 1.79% 5.71% 6.06% 4.55%
FCF / Net Income (%) 330.74% 132.96% 52.46% 2,380.62% 1,778.51% 96.49% 103.06% 79.56%

Profitability

        
ROA 4.15% 2.65% 15.75% 0.28% 2.84% 6.44% 5.55% 5.14%
ROE 8.14% 5.89% 35.4% 0.59% 6.04% 11.79% 10.55% 9.81%

Financial Health

        
Leverage (Debt/EBITDA) 1.35x 1.37x 0.65x 2.14x 1.83x 1.28x 1.14x 1.04x
Debt / Free cash flow 1.28x 6.58x 2.19x 3.21x 15.04x 3.59x 3.02x 3.63x

Capital Intensity

        
CAPEX / Current Assets (%) 6.27% 4.9% 3.83% 7.29% 7.48% 7.92% 8.07% 8.17%
CAPEX / EBITDA (%) 34.05% 28.16% 18.83% 66.17% 50.81% 49.63% 50.3% 51.38%
CAPEX / FCF (%) 32.2% 135.51% 63.21% 99.13% 418.55% 138.7% 133.22% 179.51%

Items per share

        
Cash flow per share 1 64.77 48.39 96.89 94.85 56.83 77.25 86.69 80.48
Change - -25.3% 100.26% -2.11% -40.09% 35.94% 12.22% -7.17%
Dividend per Share 1 38 50 65 5 5 15.77 15.27 17.04
Change - 31.58% 30% -92.31% 0% 215.37% -3.18% 11.61%
Book Value Per Share 1 262.5 246.5 348 313.1 309.5 320.3 339.3 356
Change - -6.11% 41.2% -10.03% -1.16% 3.5% 5.92% 4.94%
EPS 1 21.97 15.37 113.1 2.017 0.5606 35.81 34.71 34.5
Change - -30.03% 636.08% -98.22% -72.21% 6,288.77% -3.08% -0.6%
Nbr of stocks (in thousands) 263,001 254,792 254,726 254,726 254,726 254,726 254,726 254,726
Announcement Date 2/9/21 2/8/22 2/8/23 2/9/24 2/7/25 - - -
1NOK
Estimates
2025 *2026 *
P/E ratio 11.1x 11.4x
PBR 1.24x 1.17x
EV / Sales 0.86x 0.84x
Yield 3.98% 3.85%
More valuation ratios * Estimated data

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
396.50NOK
Average target price
361.62NOK
Spread / Average Target
-8.80%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. YAR Stock
  4. Financials Yara International ASA